
Algeria's Saidal group signed on Tuesday a partnership agreement with the Jordan-based Arab Company for Drug Industries and Medical Appliances (ACDIMA) to carry out bio-equivalence studies in Algeria, the official Algerian news agency APS reported.
According to the agreement, the two sides will create a joint venture to carry out "compliance studies of generic drugs with the original ones." The joint-venture, in which Saidal will hold a 60-percent ownership and Acdima 40 percent, will be "squarely independent" from Saidal for transparency reasons, the Algerian firm said.
Generic manufacturers in Algeria currently buy their pharmaceutical records in order to use them in the domestic drug production.
ACDIMA is a pan-Arab shareholding company established by a resolution from the Arab Economic Unity Council in 1976. It aims to build relations with multinational bodies to assist in setting up and participating in projects in the Arab World.
Saisal is an Algerian company founded by the government in 1982.
GMT 17:47 2018 Monday ,15 January
‘Negative’ outlook for Gulf sovereign ratings in 2018, says Moody’sGMT 19:27 2018 Sunday ,07 January
UAE pledges to distribute 70% of VAT proceeds to help fund community projectsGMT 19:21 2018 Sunday ,07 January
Surge in foreign fund inflows sets stage for Egyptian boomGMT 19:15 2018 Sunday ,07 January
Iraq to export Kirkuk oil to Iran before January-endGMT 11:35 2018 Wednesday ,03 January
Saudi Food and Drug Authority: No VAT on human medicines, vitamins, and registered medical equipmentGMT 10:00 2018 Wednesday ,03 January
Saudi Customs launches Approved Economic Operator programGMT 07:30 2018 Wednesday ,03 January
Morocco’s 2017 Economic Growth: GDP on the Rise, Investment in DeclineGMT 18:33 2018 Monday ,01 January
No New Year cheer for UAE property market
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor